High Court Vacates 2 Pay-For-Delay Rulings Post-Actavis
The U.S. Supreme Court on Monday vacated a ruling that Merck & Co. Inc.'s so-called pay-for-delay deals with two generic-drug makers were anti-competitive, remanding the case and telling the Third Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article